Financial statements Master Pharm
Balance sheet of Master Pharm
Company age:
Age:
10 y. 5 m. 15 d.
Share capital:
Share capital:
185 000 PLN
Balance sheet data of MASTER PHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 133 711 844,46 | 100 046 378,06 |
| A. Fixed assets | 54 314 220,24 | 15 978 365,25 |
| B. Current assets | 42 664 289,54 | 40 740 437,83 |
| C. Share capital contributions (basic funds) | 0,00 | - |
| D. Own shares (stocks) | 36 733 334,68 | 43 327 574,98 |
| Total liabilities | 133 711 844,46 | 100 046 378,06 |
| A. Equity | 94 518 585,18 | 67 933 469,58 |
| B. Liabilities and provisions for liabilities | 39 193 259,28 | 32 112 908,48 |
| I. Long-term liabilities | 22 500 000,00 | 23 076 411,09 |
| II. Short-term liabilities | 14 482 895,11 | 5 943 171,14 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.